Technological Innovation and Digital Transformation in the Gene Therapy for Age-Related Macular Degeneration Market
The ophthalmic gene therapy industry is experiencing a technological renaissance, driven by advances in vector technology, gene editing, and artificial intelligence. The Gene Therapy for Age-Related Macular Degeneration Market is at the forefront of these innovations, valued at USD 1 billion in 2025 and projected to reach USD 5 billion by 2035 at a CAGR of 13.1%. This article explores...
0 Comments 0 Shares 60 Views 0 Reviews